Fig 1.
Patient flow in the study comparing high and low CHA2DS2-VASc score.
Table 1.
Characteristics and comorbidities of patients at baseline.
Table 2.
The association of CHA2DS2-VASc score and 1 year outcomes.
Table 3.
The association of atrial fibrillation and 1 year outcomes.
Fig 2.
(A) Time-to-Event curves for the major adverse cardiovascular and cerebrovascular events; (B) Kaplan-Meier survival curves for all-cause mortality.
Fig 3.
1 year MACCE associated with individual risk factor of CHA2DS2-VASc score.